Cytisine | Cytisus Extract 98% High Purity Pharmaceutical Alkaloid Powder
High Purity Cytisine | Pharmaceutical Standard Alkaloid Raw Material
- Services: Bulk stock, custom purity/mesh, OEM repacking, full COA MSDS HPLC chromatogram
Cytisine | Cytisus Extract 98% High Purity Pharmaceutical Alkaloid Powder
Product Features
- Product Name: Cytisine (Also named Sparteine, Cytisus Alkaloid)
- Common Name: Cytisine / Sparteine
- Latin Raw Herb: Cytisus laborinum
- CAS No.: 485-35-8
- Core Active Ingredient: Cytisine (Quinolizidine Alkaloid)
- Assay Standard: ≥98% (Tested by Pharmacopoeia HPLC)
- Appearance: White crystalline fine powder
- Solubility: Freely soluble in water, methanol, ethanol; slightly soluble in acetone, insoluble in petroleum ether
- Extraction Process: Acidic water extraction + ion exchange resin separation + chromatographic purification
- Grade: Pharmaceutical Grade, Research Reference Grade
- Certifications: cGMP, ISO22000, S third-party full test reports
- Mesh Size: 80–100 mesh, customized ultra-fine powder available
- MOQ: 1 KG
- Free Sample: 5–20g for lab formula & third-party testing
- Shelf Life: 24 months (Sealed, light-proof, store at 2–8℃ low temperature)
- Packaging: 1kg vacuum foil bag, 25kg light-proof fiber drum with double PE liner
Detailed Introduction of Cytisine
Cytisine is a natural quinolizidine alkaloid purified from the whole herb of medicinal plant Cytisus laborinum. It is the core active raw material recognized worldwide for smoking cessation pharmaceutical preparations. Our dual purification technology combining ion exchange resin and preparative chromatography is processed under low temperature and dark environment to prevent thermal degradation of cytisine. The finished product steadily reaches ≥98% purity. Impurities, residual solvents and heavy metals are strictly controlled to meet USP, EP and Chinese pharmacopoeia standards for pharmaceutical raw materials.
Cytisine targets nicotinic acetylcholine receptors, gently relieve craving, irritability, anxiety and other withdrawal symptoms caused by nicotine dependence. It also shows respiratory soothing, antioxidant and anti-inflammatory pharmacological activities, widely used in smoking cessation tablets, lozenges and oral sprays. Meanwhile, it acts as pharmacopoeia standard reference substance supplied to pharmaceutical R&D labs and universities globally.
We only produce 98% pharmaceutical-grade cytisine without low-purity crude extracts. Full pharmacopoeia inspection is carried out for each batch with complete chromatograms and export certificates. We support lab samples and ton-level bulk supply, custom particle size & repacking specifications, delivering one-stop raw material service for global pharmaceutical factories and research institutes.
Core Efficacy of Cytisine
Block Nicotine Receptors & Relieve Tobacco Craving
Competitively bind nicotinic receptors, reduce smoking desire and withdrawal irritability.
Safe Smoking Cessation Auxiliary Agent
Mild nerve regulation with lower irritation than nicotine replacement products for oral quit-smoking formulas.
Respiratory Tract Soothing & Repair
Alleviate airway mucosal irritation, relieve cough and throat discomfort for quit-smoking lozenges.
Natural Antioxidant Activity
Scavenge free radicals and reduce oxidative damage to respiratory cells.
Internal Anti-Inflammatory Effect
Inhibit release of respiratory inflammatory factors to ease mild airway inflammation.
Standard Lab Reference Substance
98% high-purity monomer for pharmacopoeia calibration experiments.
Core Advantages of Cytisine
Pharmacopoeia grade 98% pure monomer without crude extracts, batch purity fluctuation ＜0.8% for high-end pharmaceuticals.
Exclusive resin chromatography purification, solvent residues far below EU & US pharmaceutical limits.
Traceable standardized Cytisus planting base with stable native alkaloid content.
Full pharmacopoeia inspection per batch, supply HPLC, COA, MSDS and third-party official documents.
Low-temperature dark sealed production, stable powder without degradation & discoloration during long storage.
Full pharmaceutical customization, samples & bulk stock, OEM repacking & specification adjustment supported.
Quality Inspection Standard Table
| Test Item | Standard Requirement |
|---|---|
| Cytisine Content (Pharma HPLC) | ≥98.0% |
| Appearance | White crystalline fine powder |
| Loss on Drying | ≤1.0% |
| Residue on Ignition | ≤0.2% |
| Total Heavy Metals | ≤10ppm |
| Pb≤2ppm, As≤1ppm, Cd≤1ppm, Hg≤0.1ppm | |
| Residual Organic Solvents | Compliant with USP / EP Pharmaceutical Standards |
| Total Plate Count | ≤500 CFU/g (Strict Pharma Standard) |
| Yeast & Mold | ≤50 CFU/g |
| Salmonella, E.coli | Negative |
Application & Dosage Guidance
Smoking Cessation Pharmaceuticals
5–10mg per tablet/lozenge, 2–3 times daily; 0.05%–0.1% dosage for oral sprays.
Respiratory Soothing Preparations
Compounded for cough & throat relief oral formulas.
Lab Standard Reference
High purity monomer for pharmacology calibration in pharmaceutical factories & universities.
Natural Anti-Inflammatory Pharma Intermediate
Raw material for new respiratory anti-inflammatory drug R&D.
Production Process of Aescin
